NIH clinical trial of investigational vaccine for COVID-19 begins
By A Mystery Man Writer
Description
Study enrolling Seattle-based healthy adult volunteers.
A new phase for clinical trials
Coronavirus Information
Potential strategies for combating COVID-19
Phase III Testing of AstraZeneca COVID-19 Vaccine Candidate Begins
Vaccines, Free Full-Text
SARS – NIH Director's Blog
Frontiers COVID-19: Emergence, Spread, Possible Treatments, and Global Burden
COVID-19 vaccine: Moderna says will begin Phase 3 trials with 30,000 participants in July
Investigational COVID-19 vaccine well-tolerated in older adults
Fourth large-scale COVID-19 vaccine trial begins in the United States
2022 Archive - COVID Vaccines Prevented 3 Million Deaths in the U.S., New Analysis Finds
from
per adult (price varies by group size)